Efficacy of Sambucol in the Treatment of Influenza
Launched by HADASSAH MEDICAL ORGANIZATION · Sep 10, 2006
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
The trial will be conducted at the Personnel Clinic, and at the Clinical virology Unit, Hadassah University Hospital.
Candidates for participation in the trial :
Patients who will present at the clinic with influenza-like symptoms; men and women ages 20 yrs- 65 yrs who will sign written informed consent
Excluded from the trial will be:
* Pregnant women or women who cannot exclude pregnancy.
* Patients with diabetes.
* Immune-suppressed patients, including patients taking immunosuppressive drugs.
* Patients with renal failure.
* Patients who received the recent influenza vaccine.
The st...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Fever ≥ 380C.
- • The presence of at least one of the following respiratory symptoms: cough, sore throat, nasal congestion/ runny nose.
- • The presence of at least one of the following systemic symptoms: headache, fatigue, myalgia, chills/sweats, malaise.
- Exclusion Criteria:
- • Pregnant women or women who cannot exclude pregnancy.
- • Patients with diabetes.
- • Immune-suppressed patients, including patients taking immunosuppressive drugs.
- • Patients with renal failure.
- • Patients who received the recent influenza vaccine.
About Hadassah Medical Organization
Hadassah Medical Organization (HMO) is a leading healthcare institution based in Jerusalem, Israel, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, HMO leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research across various therapeutic areas. The organization is dedicated to fostering collaboration between clinical researchers, healthcare professionals, and academic institutions, ensuring the highest standards of ethical practice and scientific rigor. HMO's mission is to translate groundbreaking research into effective treatments, ultimately enhancing health outcomes for diverse populations both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Dana G Wolf, MD
Principal Investigator
Hadassah Medical Organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials